All In Biotech

Drug Trial Radar · NCT02915705

Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH

A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)

Last checked: Nov 20, 2026Latest source record: Aug 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

61

Actual

Start

Sep 8, 2016

Primary completion

Feb 12, 2018

Study completion Jul 15, 2019

Sponsor

Lead sponsor
Kyowa Kirin, Inc.Industry
Sponsor type
Industry
Collaborators
Kyowa Kirin Co., Ltd.
First posted
Sep 27, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 year, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the effect of KRN23 (burosumab) therapy in improving rickets in children with XLH compared with active control (oral phosphate/active vitamin D).

Conditions

  • X-Linked Hypophosphatemia

Interventions

  • burosumabBiological

    solution for subcutaneous (SC) injection

  • Oral Phosphate SupplementDrug

    oral tablet; oral solution; oral powder

  • active vitamin DDrug

    tablet, oral solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Radiographic Global Impression of Change (RGI-C) Global Score at Week 40Time frame: Week 40

Locations

16 sites in 7 countries. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California

  • UCSF

    San Francisco, California

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • Shriners Hospital For Children

    St Louis, Missouri

  • Vanderbilt Children's Hospital

    Nashville, Tennessee

  • The Children's Hospital at Westmead

    Westmead, New South Wales, Australia

  • Children's Hospital of Eastern Ontario (CHEO) Research Institute

    Ottawa, Ontario, Canada

  • The Hospital for Sick Children

    Toronto, Ontario, Canada

  • Shriners Hospital for Children - Canada

    Montreal, Quebec, Canada

  • Okayama Saiseikai General Hospital

    Okayama, Japan

  • Japan Community Healthcare Organization Osaka Hospital

    Osaka, Japan

  • Kanagawa Children's Medical Center

    Yokohama, Kanagawa, Japan

  • Seoul National University Hospital

    Seoul, South Korea

  • Karolinska Institutet and University Hospital

    Stockholm, Sweden

  • Birmingham Children's Hospital

    Birmingham, United Kingdom

  • Royal Manchester Children's Hospital - University of Manchester

    Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.